Sign in
8-K

Current Report

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-22-084094

Executive or director change · Shareholder vote results

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading ea171085-8k_actinium.htm…